- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
From InvestorPlace
FDA Gives Green Signal To Second Omicron-Adapted Booster Shots For People At High Risk From Covid
April 18, 2023
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 17, 2023
From Benzinga
US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma
April 12, 2023
From Benzinga
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
From Benzinga
Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots
April 04, 2023
From Benzinga
From Benzinga
From Benzinga
BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday
March 27, 2023
From Benzinga
Earnings Scheduled For March 27, 2023
March 27, 2023
From Benzinga
First Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trial
March 27, 2023
From MarketWatch
US Stocks Poised To Start New Trading Week Higher On Hopes Of Resolving Banking Crisis: Analyst Warns 'No News Would Be Good News'
March 27, 2023
From Benzinga
Could CRISPR Therapeutics Become the Next Moderna?
March 27, 2023
From Motley Fool
Carnival, BioNTech And 3 Stocks To Watch Heading Into Monday
March 27, 2023
From Benzinga
Investor Fear Increases Amid Recent Bank Concerns
March 27, 2023
From Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
From InvestorPlace
From MarketWatch
China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine
March 22, 2023
From Benzinga
Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks
March 21, 2023
From Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
From Benzinga
Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose
March 21, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.